{"success":true,"data":{"pressRelease":{"id":"39184","rtpr_id":"nGNXzgkCZ","ticker":"HSCS","exchange":"NASDAQ","all_tickers":["HSCS","HSCSW"],"title":"HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network","author":"Globe Newswire","published_at":"2026-05-19T12:30:00.509Z","article_body":"Southlake, TX, May 19, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc.\n(https://www.globenewswire.com/Tracker?data=sDBooAnIeD9fEgq2dYenoA5iAZrdUbKLcDelcXblOEDeYDvPUUIA0sMRjOUpuOUpOIBDxBZNBDv_gCDo8F6Gk2n4qrgnzvPpz2RdMwPbBSw=)\n(Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare\ninformation technology (“HIT”) company focused on advancing\nelectrocardiography (“ECG” or “EKG”) through the integration of\nartificial intelligence (“AI”), today announced that it has entered into a\ncommercial agreement with North Shore Health, a community hospital serving\nCook County, Minnesota and the surrounding region, to deploy the MyoVista\nInsights™ platform.\n\nNorth Shore Health is part of the Cibolo Rural Health Networks (“Cibolo\nHealth”) network, which previously selected MyoVista Insights as its\nendorsed ECG management platform for hospitals within its high-value networks.\nThe agreement represents another SaaS-based revenue deployment for\nHeartSciences and further supports the Company’s commercial rollout of\nMyoVista Insights. The cloud-native, device-agnostic platform is designed to\nimprove workflow efficiency, support enterprise-grade EHR interoperability,\nand create a scalable foundation for the use of cleared AI-ECG algorithms\nwithin routine clinical workflows.\n\nAndrew Simpson, Chief Executive Officer of HeartSciences, said, “We are very\npleased to welcome North Shore Health as a commercial customer for MyoVista\nInsights. This agreement is particularly significant as the first deployment\nwithin the Cibolo Health network following Cibolo’s endorsement of MyoVista\nInsights earlier this year, and we believe it demonstrates the potential for\nfurther adoption across Cibolo’s network of 127 independent hospitals. We\nare encouraged by the breadth of commercial interest we are seeing and remain\nfocused on building sustained commercial momentum across healthcare\norganizations of all sizes.”\n\nBrian Hady, Director of Imaging at North Shore Health, added, “North Shore\nHealth strives to provide the best cardiac care to every patient we serve, and\nMyoVista Insights gives our clinicians a meaningful new capability to do that\nmore effectively. The platform modernizes how we manage ECG data, integrates\nwith the way our clinicians already work, and creates a foundation to bring\nfurther AI-driven advances to our patients over time. For our community, that\nis a real step forward in care.”\n\nAbout HeartSciences\n\nHeartSciences is a healthcare information technology (“HIT”) company\nadvancing the use of ECG/EKGs through the integration of artificial\nintelligence (“AI”). The Company’s MyoVista Insights platform is a\ndevice-agnostic, next-generation ECG management system designed to improve\nclinical efficiency and decision-making. Its MyoVista wavECG device is\ndesigned to deliver conventional ECG functionality while supporting on-device\nAI-enabled solutions.\n\nFor more information, please visit: https://www.heartsciences.com. X:\n@HeartSciences\n\nAbout North Shore Health\n\nNorth Shore Health is a rural health facility located in Grand Marais,\nMinnesota, on the north shore of Lake Superior, and is a hospital within the\nCibolo Health network. Part of the Cook County Hospital District, North Shore\nHealth includes a critical access hospital, skilled nursing facility, home\nhealth agency, ambulance service, and a variety of diagnostic and therapeutic\nservices. The organization is focused on providing community access to\ncompassionate, high-quality care for residents and visitors across Cook County\nand the surrounding region. For more information, please visit\nwww.northshorehealthgm.org.\n\nSafe Harbor Statement\n\nThis announcement contains forward-looking statements within the meaning of\nSection 27A of the Securities Act of 1933, as amended, and Section 21E of the\nSecurities Exchange Act of 1934, as amended. These forward-looking statements\nare made under the “safe harbor” provisions of the Private Securities\nLitigation Reform Act of 1995 and are relating to the Company’s future\nfinancial and operating performance. All statements, other than statements of\nhistorical facts, included herein are “forward-looking statements”\nincluding, among other things, statements about HeartSciences’ beliefs and\nexpectations. These statements are based on current expectations, assumptions\nand uncertainties involving judgments about, among other things, future\neconomic, competitive and market conditions and future business decisions, all\nof which are difficult or impossible to predict accurately and many of which\nare beyond the Company’s control. The expectations reflected in these\nforward-looking statements involve significant assumptions, risks and\nuncertainties, and these expectations may prove to be incorrect. Investors\nshould not place undue reliance on these forward-looking statements, which\nspeak only as of the date of this press release. Potential risks and\nuncertainties include, but are not limited to, risks discussed in\nHeartSciences’ Annual Report on Form 10-K for the fiscal year ended April\n30, 2025, filed with the U.S. Securities and Exchange Commission (the\n“SEC”) on July 24, 2025, HeartSciences’ Quarterly Report on Form 10-Q\nfor the fiscal quarter ended July 31, 2025 filed with the SEC on September 11,\n2025, HeartSciences’ Quarterly Report on Form 10-Q for the fiscal quarter\nended October 31, 2025 filed with the SEC on December 15, 2025,\nHeartSciences’ Quarterly Report on Form 10-Q for the fiscal quarter ended\nJanuary 31, 2026 filed with the SEC on March 16, 2026, and in HeartSciences’\nother filings with the SEC at www.sec.gov. Other than as required under the\nsecurities laws, the Company does not assume a duty to update these\nforward-looking statements.\n\nInvestor Relations:\nIntegrous Communications\nMark Komonoski, Partner\nPhone: 877 255 8483\nEmail: mkomonoski@integcom.us\n\nMedia Contact:\nHeartSciences\nGene Gephart\nPhone: +1 682 244 2578 Ext. 2024\nEmail: info@heartsciences.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/800a6aae-74f3-42bb-9199-5e169ed9b881)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNXzgkCZ","title":"HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network","author":"Globe Newswire","ticker":"HSCS","created":"2026-05-19T12:30:00.509Z","tickers":["HSCS","HSCSW"],"exchange":"NASDAQ","article_body":"Southlake, TX, May 19, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc.\n(https://www.globenewswire.com/Tracker?data=sDBooAnIeD9fEgq2dYenoA5iAZrdUbKLcDelcXblOEDeYDvPUUIA0sMRjOUpuOUpOIBDxBZNBDv_gCDo8F6Gk2n4qrgnzvPpz2RdMwPbBSw=)\n(Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare\ninformation technology (“HIT”) company focused on advancing\nelectrocardiography (“ECG” or “EKG”) through the integration of\nartificial intelligence (“AI”), today announced that it has entered into a\ncommercial agreement with North Shore Health, a community hospital serving\nCook County, Minnesota and the surrounding region, to deploy the MyoVista\nInsights™ platform.\n\nNorth Shore Health is part of the Cibolo Rural Health Networks (“Cibolo\nHealth”) network, which previously selected MyoVista Insights as its\nendorsed ECG management platform for hospitals within its high-value networks.\nThe agreement represents another SaaS-based revenue deployment for\nHeartSciences and further supports the Company’s commercial rollout of\nMyoVista Insights. The cloud-native, device-agnostic platform is designed to\nimprove workflow efficiency, support enterprise-grade EHR interoperability,\nand create a scalable foundation for the use of cleared AI-ECG algorithms\nwithin routine clinical workflows.\n\nAndrew Simpson, Chief Executive Officer of HeartSciences, said, “We are very\npleased to welcome North Shore Health as a commercial customer for MyoVista\nInsights. This agreement is particularly significant as the first deployment\nwithin the Cibolo Health network following Cibolo’s endorsement of MyoVista\nInsights earlier this year, and we believe it demonstrates the potential for\nfurther adoption across Cibolo’s network of 127 independent hospitals. We\nare encouraged by the breadth of commercial interest we are seeing and remain\nfocused on building sustained commercial momentum across healthcare\norganizations of all sizes.”\n\nBrian Hady, Director of Imaging at North Shore Health, added, “North Shore\nHealth strives to provide the best cardiac care to every patient we serve, and\nMyoVista Insights gives our clinicians a meaningful new capability to do that\nmore effectively. The platform modernizes how we manage ECG data, integrates\nwith the way our clinicians already work, and creates a foundation to bring\nfurther AI-driven advances to our patients over time. For our community, that\nis a real step forward in care.”\n\nAbout HeartSciences\n\nHeartSciences is a healthcare information technology (“HIT”) company\nadvancing the use of ECG/EKGs through the integration of artificial\nintelligence (“AI”). The Company’s MyoVista Insights platform is a\ndevice-agnostic, next-generation ECG management system designed to improve\nclinical efficiency and decision-making. Its MyoVista wavECG device is\ndesigned to deliver conventional ECG functionality while supporting on-device\nAI-enabled solutions.\n\nFor more information, please visit: https://www.heartsciences.com. X:\n@HeartSciences\n\nAbout North Shore Health\n\nNorth Shore Health is a rural health facility located in Grand Marais,\nMinnesota, on the north shore of Lake Superior, and is a hospital within the\nCibolo Health network. Part of the Cook County Hospital District, North Shore\nHealth includes a critical access hospital, skilled nursing facility, home\nhealth agency, ambulance service, and a variety of diagnostic and therapeutic\nservices. The organization is focused on providing community access to\ncompassionate, high-quality care for residents and visitors across Cook County\nand the surrounding region. For more information, please visit\nwww.northshorehealthgm.org.\n\nSafe Harbor Statement\n\nThis announcement contains forward-looking statements within the meaning of\nSection 27A of the Securities Act of 1933, as amended, and Section 21E of the\nSecurities Exchange Act of 1934, as amended. These forward-looking statements\nare made under the “safe harbor” provisions of the Private Securities\nLitigation Reform Act of 1995 and are relating to the Company’s future\nfinancial and operating performance. All statements, other than statements of\nhistorical facts, included herein are “forward-looking statements”\nincluding, among other things, statements about HeartSciences’ beliefs and\nexpectations. These statements are based on current expectations, assumptions\nand uncertainties involving judgments about, among other things, future\neconomic, competitive and market conditions and future business decisions, all\nof which are difficult or impossible to predict accurately and many of which\nare beyond the Company’s control. The expectations reflected in these\nforward-looking statements involve significant assumptions, risks and\nuncertainties, and these expectations may prove to be incorrect. Investors\nshould not place undue reliance on these forward-looking statements, which\nspeak only as of the date of this press release. Potential risks and\nuncertainties include, but are not limited to, risks discussed in\nHeartSciences’ Annual Report on Form 10-K for the fiscal year ended April\n30, 2025, filed with the U.S. Securities and Exchange Commission (the\n“SEC”) on July 24, 2025, HeartSciences’ Quarterly Report on Form 10-Q\nfor the fiscal quarter ended July 31, 2025 filed with the SEC on September 11,\n2025, HeartSciences’ Quarterly Report on Form 10-Q for the fiscal quarter\nended October 31, 2025 filed with the SEC on December 15, 2025,\nHeartSciences’ Quarterly Report on Form 10-Q for the fiscal quarter ended\nJanuary 31, 2026 filed with the SEC on March 16, 2026, and in HeartSciences’\nother filings with the SEC at www.sec.gov. Other than as required under the\nsecurities laws, the Company does not assume a duty to update these\nforward-looking statements.\n\nInvestor Relations:\nIntegrous Communications\nMark Komonoski, Partner\nPhone: 877 255 8483\nEmail: mkomonoski@integcom.us\n\nMedia Contact:\nHeartSciences\nGene Gephart\nPhone: +1 682 244 2578 Ext. 2024\nEmail: info@heartsciences.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/800a6aae-74f3-42bb-9199-5e169ed9b881)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-05-19T12:30:00.551934603Z","server_sent_at_ms":1779193800551},"received_at":"2026-05-19T12:30:00.648Z","source_url":null},"analysis":{"id":"28623","press_release_id":"39184","analysis_json":{"industry":{"label":"Health Care Information Services","sector":"Health Care"},"redFlags":[],"eventType":"partnership","narrative":"HeartSciences signed a commercial agreement with North Shore Health to deploy its MyoVista Insights AI-ECG platform.\n\nThis marks the first hospital deployment within the Cibolo Health network, which previously endorsed the platform for its 127 independent hospitals.\n\nManagement views this as a proof point for broader adoption across the Cibolo network and a step toward sustained commercial momentum.","sentiment":"bullish","agentHooks":{"shouldPost":true,"suggestedAngle":"First-in-network commercial win for HeartSciences at Cibolo Health -- watch for follow-on deals across the 127-hospital system."},"keyFigures":{"customDimensions":{"network_hospital_count":127}},"quotedText":"This agreement is particularly significant as the first deployment within the Cibolo Health network following Cibolo’s endorsement of MyoVista Insights earlier this year, and we believe it demonstrates the potential for further adoption across Cibolo’s network of 127 independent hospitals.","namedEntities":{"people":[{"name":"Andrew Simpson","role":"CEO"},{"name":"Brian Hady","role":"Director of Imaging"}],"products":["MyoVista Insights","MyoVista wavECG"],"companies":[{"name":"HeartSciences Inc.","ticker":"HSCS"},{"name":"North Shore Health","relationship":"customer"},{"name":"Cibolo Health","relationship":"network partner"}],"dollarAmounts":[]},"materialImpact":{"score":3,"reasoning":"First commercial deployment within a major hospital network (Cibolo Health, 127 hospitals) validates the SaaS model and suggests potential for significant scale. It is a single-hospital contract, not a full-network deal, so impact is moderate but positive."},"tickerRelevance":{"others":[],"primary":"HSCS"},"globalImportance":25,"audienceRelevance":30,"eventTypeSecondary":["operations_update"],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"commercial_validation","sectorWeight":"high","householdBrandBoost":0,"marketCapAdjustment":"neutral","retailFavoriteBoost":0}},"event_type":"partnership","event_type_secondary":["operations_update"],"sentiment":"bullish","material_impact_score":3,"narrative":"HeartSciences signed a commercial agreement with North Shore Health to deploy its MyoVista Insights AI-ECG platform.\n\nThis marks the first hospital deployment within the Cibolo Health network, which previously endorsed the platform for its 127 independent hospitals.\n\nManagement views this as a proof point for broader adoption across the Cibolo network and a step toward sustained commercial momentum.","key_figures":{"customDimensions":{"network_hospital_count":127}},"named_entities":{"people":[{"name":"Andrew Simpson","role":"CEO"},{"name":"Brian Hady","role":"Director of Imaging"}],"products":["MyoVista Insights","MyoVista wavECG"],"companies":[{"name":"HeartSciences Inc.","ticker":"HSCS"},{"name":"North Shore Health","relationship":"customer"},{"name":"Cibolo Health","relationship":"network partner"}],"dollarAmounts":[]},"model_name":"qwen3_6_27b_awq","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-05-19T12:31:42.902Z","global_importance":25,"audience_relevance":30,"importance_components":{"tickerTier":"small-cap","eventGravity":"commercial_validation","sectorWeight":"high","householdBrandBoost":0,"marketCapAdjustment":"neutral","retailFavoriteBoost":0}},"durationMs":18970,"modelName":"george-droid-qwen-72b"}}